ICD-10-CM Codes
C00-D49 Neoplasms
C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
C88- Malignant immunoproliferative diseases and certain other B-cell lymphomas
2022 ICD-10-CM Diagnosis Code C88

2022 ICD-10-CM Diagnosis Code C88

Malignant immunoproliferative diseases and certain other B-cell lymphomas

2016

2017

2018

2019

2020

2021

2022

Non-Billable/Non-Specific Code

C88 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
Short description: Malig immunoproliferative dis and certain oth B-cell lymph
The 2022 edition of ICD-10-CM C88 became effective on October 1, 2021.
This is the American ICD-10-CM version of C88 - other international versions of ICD-10 C88 may differ.

Type 1 Excludes

Type 1 Excludes Help

A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C88. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

B-cell lymphoma, unspecified (
ICD-10-CM Diagnosis Code C85.1
Unspecified B-cell lymphoma
Note
- If B-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
C85.1-
)
personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (
ICD-10-CM Diagnosis Code Z85.79
Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
Applicable To
- Conditions classifiable to C88-C90, C96
Type 1 Excludes
- multiple myeloma in remission (C90.01)
- plasma cell leukemia in remission (C90.11)
- plasmacytoma in remission (C90.21)
Z85.79
)

The following code(s) above C88 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to C88:

C00-D49
2022 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms
C81-C96
2022 ICD-10-CM Range C81-C96
Malignant neoplasms of lymphoid, hematopoietic and related tissue
Type 2 Excludes
- Kaposi's sarcoma of lymph nodes (C46.3)
- secondary and unspecified neoplasm of lymph nodes (C77.-)
- secondary neoplasm of bone marrow (C79.52)
- secondary neoplasm of spleen (C78.89)
Malignant neoplasms of lymphoid, hematopoietic and related tissue

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change

Code annotations containing back-references to C88:

Type 1 Excludes: C77

ICD-10-CM Diagnosis Code C77
Secondary and unspecified malignant neoplasm of lymph nodes
Type 1 Excludes
- malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
- mesentary metastasis of carcinoid tumor (C7B.04)
- secondary carcinoid tumors of distant lymph nodes (C7B.01)

ICD-10-CM Codes Adjacent To C88

C85.98 …… lymph nodes of multiple sites

C85.99 …… extranodal and solid organ sites

C86 Other specified types of T/NK-cell lymphoma

C86.0 Extranodal NK/T-cell lymphoma, nasal type

C86.1 Hepatosplenic T-cell lymphoma

C86.2 Enteropathy-type (intestinal) T-cell lymphoma

C86.3 Subcutaneous panniculitis-like T-cell lymphoma

C86.4 Blastic NK-cell lymphoma

C86.5 Angioimmunoblastic T-cell lymphoma

C86.6 Primary cutaneous CD30-positive T-cell proliferations

C88 Malignant immunoproliferative diseases and certain other B-cell lymphomas

C88.0 Waldenström macroglobulinemia

C88.2 Heavy chain disease

C88.3 Immunoproliferative small intestinal disease

C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]

C88.8 Other malignant immunoproliferative diseases

C88.9 Malignant immunoproliferative disease, unspecified

C90 Multiple myeloma and malignant plasma cell neoplasms

C90.0 Multiple myeloma

C90.00 …… not having achieved remission

C90.01 …… in remission

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2022 ICD-10-CM Diagnosis Code C88

Malignant immunoproliferative diseases and certain other B-cell lymphomas

Unspecified B-cell lymphoma

Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues

Neoplasms

Malignant neoplasms of lymphoid, hematopoietic and related tissue

Secondary and unspecified malignant neoplasm of lymph nodes